|
2 |
|
3 |
Fund Performance Overview | |
|
4 |
|
6 |
|
8 |
|
10 |
|
12 |
|
14 |
|
16 |
|
18 |
|
20 |
|
21 |
Portfolio of Investments | |
|
23 |
|
24 |
|
25 |
|
26 |
|
27 |
|
28 |
|
29 |
|
31 |
|
34 |
|
36 |
|
38 |
|
42 |
|
50 |
|
58 |
Performance | |||||||
Average Annual Total Returns | Cumulative Total Returns | ||||||
6
Months Ended 9/30/21 |
1
Year Ended 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 | ||
Fund Performance | |||||||
NAV | 5.63% | 96.57% | 12.76% | 12.82% | 82.32% | 83.41% | |
Market Price | 5.73% | 96.80% | 12.69% | 12.84% | 81.71% | 83.52% | |
Index Performance | |||||||
Nasdaq US Smart Banks IndexTM | 6.01% | 98.23% | 13.54% | 13.60% | 88.68% | 89.85% | |
NASDAQ US Benchmark Banks Index | 8.51% | 85.58% | 15.95% | 15.78% | 109.55% | 108.93% | |
NASDAQ US Benchmark Index | 8.40% | 32.02% | 17.03% | 17.27% | 119.50% | 122.74% |
Performance | |||||||
Average Annual Total Returns | Cumulative Total Returns | ||||||
6
Months Ended 9/30/21 |
1
Year Ended 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 | ||
Fund Performance | |||||||
NAV | -5.23% | 16.50% | 5.10% | 5.30% | 28.22% | 29.64% | |
Market Price | -6.62% | 16.05% | 5.08% | 5.30% | 28.09% | 29.63% | |
Index Performance | |||||||
Nasdaq US Smart Food & Beverage IndexTM | -4.97% | 17.28% | 5.77% | 5.98% | 32.38% | 33.88% | |
NASDAQ US Benchmark Food, Beverage and Tobacco Index | 0.03% | 14.16% | 7.33% | 7.62% | 42.45% | 44.69% | |
NASDAQ US Benchmark Index | 8.40% | 32.02% | 17.03% | 17.27% | 119.50% | 122.74% |
Performance | |||||||
Average Annual Total Returns | Cumulative Total Returns | ||||||
6
Months Ended 9/30/21 |
1
Year Ended 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 | ||
Fund Performance | |||||||
NAV | 23.47% | 106.17% | -0.06% | 1.02% | -0.31% | 5.22% | |
Market Price | 23.46% | 106.50% | -0.06% | 1.03% | -0.30% | 5.28% | |
Index Performance | |||||||
Nasdaq US Smart Oil & Gas IndexTM | 24.05% | 108.32% | 0.60% | 1.68% | 3.01% | 8.75% | |
NASDAQ US Benchmark Energy Index | 9.48% | 86.93% | -1.21% | -0.07% | -5.91% | -0.36% | |
NASDAQ US Benchmark Index | 8.40% | 32.02% | 17.03% | 17.27% | 119.50% | 122.74% |
Performance | |||||||
Average Annual Total Returns | Cumulative Total Returns | ||||||
6
Months Ended 9/30/21 |
1
Year Ended 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 | ||
Fund Performance | |||||||
NAV | 0.28% | 7.58% | 6.32% | 6.00% | 35.88% | 34.05% | |
Market Price | 0.32% | 7.62% | 6.32% | 6.02% | 35.84% | 34.16% | |
Index Performance | |||||||
Nasdaq US Smart Pharmaceuticals IndexTM | 0.63% | 8.07% | 7.01% | 6.69% | 40.31% | 38.49% | |
NASDAQ US Benchmark Pharmaceuticals Index | 6.09% | 15.98% | 11.54% | 11.38% | 72.63% | 71.92% | |
NASDAQ US Benchmark Index | 8.40% | 32.02% | 17.03% | 17.27% | 119.50% | 122.74% |
Performance | |||||||
Average Annual Total Returns | Cumulative Total Returns | ||||||
6
Months Ended 9/30/21 |
1
Year Ended 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 | ||
Fund Performance | |||||||
NAV | 8.63% | 28.99% | 12.58% | 12.50% | 80.81% | 80.81% | |
Market Price | 8.59% | 28.98% | 12.57% | 12.51% | 80.77% | 80.87% | |
Index Performance | |||||||
Nasdaq US Smart Retail IndexTM | 9.03% | 29.88% | 13.32% | 13.23% | 86.83% | 86.80% | |
NASDAQ US Benchmark Retail Index | 7.08% | 14.94% | 20.76% | 21.09% | 156.80% | 161.73% | |
NASDAQ US Benchmark Index | 8.40% | 32.02% | 17.03% | 17.27% | 119.50% | 122.74% |
Performance | |||||||
Average Annual Total Returns | Cumulative Total Returns | ||||||
6
Months Ended 9/30/21 |
1
Year Ended 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 | ||
Fund Performance | |||||||
NAV | 4.12% | 41.10% | 27.46% | 28.19% | 236.36% | 248.51% | |
Market Price | 4.23% | 41.37% | 27.33% | 28.23% | 234.75% | 249.03% | |
Index Performance | |||||||
Nasdaq US Smart Semiconductor IndexTM | 4.45% | 42.03% | 28.28% | 29.03% | 247.35% | 260.10% | |
NASDAQ US Benchmark Semiconductors Index | 11.26% | 36.10% | 27.73% | 28.49% | 240.02% | 252.71% | |
NASDAQ US Benchmark Index | 8.40% | 32.02% | 17.03% | 17.27% | 119.50% | 122.74% |
Performance | |||||||
Average Annual Total Returns | Cumulative Total Returns | ||||||
6
Months Ended 9/30/21 |
1
Year Ended 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 |
5
Years Ended 9/30/21 |
Inception (9/20/16) to 9/30/21 | ||
Fund Performance | |||||||
NAV | -5.80% | 32.62% | 9.64% | 10.23% | 58.40% | 63.17% | |
Market Price | -5.89% | 32.52% | 9.61% | 10.22% | 58.19% | 63.11% | |
Index Performance | |||||||
Nasdaq US Smart Transportation IndexTM | -5.89% | 32.90% | 10.21% | 10.80% | 62.56% | 67.49% | |
NASDAQ US Benchmark Industrial Transportation Index | -3.59% | 15.39% | 17.05% | 17.83% | 119.73% | 128.16% | |
NASDAQ US Benchmark Index | 8.40% | 32.02% | 17.03% | 17.27% | 119.50% | 122.74% |
Performance | ||
Cumulative Total Returns | ||
Inception
(6/22/21) to 9/30/21 | ||
Fund Performance | ||
NAV | 2.70% | |
Market Value | 2.94% | |
Index Performance | ||
Indxx Global Medical Equipment Index | 3.09% | |
MSCI World Health Care Index | 1.52% |
Beginning Account Value April 1, 2021 |
Ending Account Value September 30, 2021 |
Annualized Expense Ratio Based on the Six-Month Period |
Expenses Paid During the Six-Month Period (a) | |
First Trust Nasdaq Bank ETF (FTXO) | ||||
Actual | $1,000.00 | $1,056.30 | 0.60% | $3.09 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,022.06 | 0.60% | $3.04 |
First Trust Nasdaq Food & Beverage ETF (FTXG) | ||||
Actual | $1,000.00 | $947.70 | 0.60% | $2.93 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,022.06 | 0.60% | $3.04 |
First Trust Nasdaq Oil & Gas ETF (FTXN) | ||||
Actual | $1,000.00 | $1,234.70 | 0.60% | $3.36 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,022.06 | 0.60% | $3.04 |
First Trust Nasdaq Pharmaceuticals ETF (FTXH) | ||||
Actual | $1,000.00 | $1,002.80 | 0.60% | $3.01 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,022.06 | 0.60% | $3.04 |
First Trust Nasdaq Retail ETF (FTXD) | ||||
Actual | $1,000.00 | $1,086.30 | 0.60% | $3.14 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,022.06 | 0.60% | $3.04 |
First Trust Nasdaq Semiconductor ETF (FTXL) | ||||
Actual | $1,000.00 | $1,041.20 | 0.60% | $3.07 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,022.06 | 0.60% | $3.04 |
Beginning Account Value April 1, 2021 |
Ending Account Value September 30, 2021 |
Annualized Expense Ratio Based on the Six-Month Period |
Expenses Paid During the Six-Month Period (a) | |
First Trust Nasdaq Transportation ETF (FTXR) | ||||
Actual | $1,000.00 | $942.00 | 0.60% | $2.92 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,022.06 | 0.60% | $3.04 |
Beginning Account Value June 22, 2021 (b) |
Ending Account Value September 30, 2021 |
Annualized Expense Ratio Based on the the Number of Days in the Period |
Expenses Paid During the Period June 22, 2021 (b) to September 30, 2021 (c) | |
First Trust Indxx Medical Devices ETF (MDEV) | ||||
Actual | $1,000.00 | $1,027.00 | 0.70% | $1.96 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,021.56 | 0.70% | $3.55 |
(a) | Expenses are equal to the annualized expense ratios as indicated in the table multiplied by the average account value over the period (April 1, 2021 through September 30, 2021), multiplied by 183/365 (to reflect the six-month period). |
(b) | Inception date. |
(c) | Actual expenses are equal to the annualized expense ratio as indicated in the table multiplied by the average account value over the period (June 22, 2021 through September 30, 2021), multiplied by 101/365. Hypothetical expenses are assumed for the most recent six-month period. |
Total Value at 9/30/2021 |
Level
1 Quoted Prices |
Level
2 Significant Observable Inputs |
Level
3 Significant Unobservable Inputs | |
Common Stocks: | ||||
Health Care Equipment & Supplies | $ 21,953,668 | $ 12,965,522 | $ 8,988,146 | $ — |
Life Sciences Tools & Services | 5,645,606 | 4,241,192 | 1,404,414 | — |
Other industry categories* | 823,951 | 823,951 | — | — |
Total Investments | $ 28,423,225 | $ 18,030,665 | $ 10,392,560 | $— |
* | See Portfolio of Investments for industry breakout. |
First
Trust Nasdaq Bank ETF (FTXO) |
First
Trust Nasdaq Food & Beverage ETF (FTXG) |
First
Trust Nasdaq Oil & Gas ETF (FTXN) | |||
ASSETS: | |||||
Investments, at value
|
$ 231,051,639 | $ 6,024,857 | $ 49,321,547 | ||
Cash
|
27,277 | 3,313 | 13,222 | ||
Receivables: | |||||
Dividends
|
412,012 | 7,500 | 887 | ||
Fund shares sold
|
3,311,116 | — | 5,735,952 | ||
Dividend reclaims
|
— | — | — | ||
Securities lending income
|
— | — | — | ||
Investment securities sold
|
— | — | 168,460 | ||
Total Assets
|
234,802,044 | 6,035,670 | 55,240,068 | ||
LIABILITIES: | |||||
Payables: | |||||
Collateral for securities on loan
|
— | — | — | ||
Investment advisory fees
|
110,914 | 3,034 | 19,883 | ||
Investment securities purchased
|
3,305,494 | — | 5,885,281 | ||
Fund shares redeemed
|
— | — | — | ||
Total Liabilities
|
3,416,408 | 3,034 | 5,905,164 | ||
NET ASSETS
|
$231,385,636 | $6,032,636 | $49,334,904 | ||
NET ASSETS consist of: | |||||
Paid-in capital
|
$ 288,038,418 | $ 6,970,339 | $ 47,085,228 | ||
Par value
|
71,000 | 2,500 | 26,000 | ||
Accumulated distributable earnings (loss)
|
(56,723,782) | (940,203) | 2,223,676 | ||
NET ASSETS
|
$231,385,636 | $6,032,636 | $49,334,904 | ||
NET ASSET VALUE, per share
|
$32.59 | $24.13 | $18.97 | ||
Number of shares outstanding (unlimited number of
shares authorized, par value $0.01 per share)
|
7,100,002 | 250,002 | 2,600,002 | ||
Investments, at cost
|
$214,026,045 | $6,316,421 | $44,887,545 | ||
Securities on loan, at value
|
$— | $— | $— |
First
Trust Nasdaq Pharmaceuticals ETF (FTXH) |
First
Trust Nasdaq Retail ETF (FTXD) |
First
Trust Nasdaq Semiconductor ETF (FTXL) |
First
Trust Nasdaq Transportation ETF (FTXR) |
First
Trust Indxx Medical Devices ETF (MDEV) | ||||
$ 17,819,186 | $ 22,125,224 | $ 80,637,505 | $ 1,146,573,647 | $ 28,423,225 | ||||
8,934 | 6,036 | 157,684 | 325,315 | 10,458 | ||||
24,737 | 12,068 | 19,662 | 372,501 | 16,313 | ||||
— | 1,702,696 | 3,365,955 | — | — | ||||
286 | — | — | 80 | 677 | ||||
— | — | — | 563,898 | — | ||||
— | — | — | 1,565,808 | — | ||||
17,853,143 | 23,846,024 | 84,180,806 | 1,149,401,249 | 28,450,673 | ||||
— | — | — | 67,094,975 | — | ||||
9,579 | 11,526 | 38,131 | 546,858 | 17,391 | ||||
— | 1,699,390 | 3,359,609 | — | — | ||||
— | — | — | 1,566,853 | — | ||||
9,579 | 1,710,916 | 3,397,740 | 69,208,686 | 17,391 | ||||
$ 17,843,564 | $ 22,135,108 | $ 80,783,066 | $ 1,080,192,563 | $ 28,433,282 | ||||
$ 18,465,202 | $ 22,600,467 | $ 70,440,835 | $ 1,066,340,742 | $ 27,905,772 | ||||
7,000 | 6,500 | 12,000 | 350,500 | 11,000 | ||||
(628,638) | (471,859) | 10,330,231 | 13,501,321 | 516,510 | ||||
$ 17,843,564 | $ 22,135,108 | $ 80,783,066 | $ 1,080,192,563 | $ 28,433,282 | ||||
$25.49 | $34.05 | $67.32 | $30.82 | $25.85 | ||||
700,002 | 650,002 | 1,200,002 | 35,050,002 | 1,100,002 | ||||
$17,131,742 | $22,268,199 | $76,729,370 | $1,131,523,915 | $27,880,166 | ||||
$— | $— | $— | $66,196,692 | $— |
First
Trust Nasdaq Bank ETF (FTXO) |
First
Trust Nasdaq Food & Beverage ETF (FTXG) |
First
Trust Nasdaq Oil & Gas ETF (FTXN) | ||||
INVESTMENT INCOME: | ||||||
Dividends
|
$ 2,857,926 | $ 69,653 | $ 792,382 | |||
Interest
|
9 | — | 3 | |||
Securities lending income (net of fees)
|
— | — | 147 | |||
Foreign withholding tax
|
(23,471) | — | — | |||
Other
|
— | — | — | |||
Total investment income
|
2,834,464 | 69,653 | 792,532 | |||
EXPENSES: | ||||||
Investment advisory fees
|
708,747 | 19,008 | 155,346 | |||
Total expenses
|
708,747 | 19,008 | 155,346 | |||
NET INVESTMENT INCOME (LOSS)
|
2,125,717 | 50,645 | 637,186 | |||
NET REALIZED AND UNREALIZED GAIN (LOSS): | ||||||
Net realized gain (loss) on: | ||||||
Investments
|
(9,590,678) | (339,905) | (1,614,088) | |||
In-kind redemptions
|
7,247,620 | 287,212 | 6,006,596 | |||
Foreign currency transactions
|
— | — | — | |||
Net realized gain (loss)
|
(2,343,058) | (52,693) | 4,392,508 | |||
Net change in unrealized appreciation (depreciation) on: | ||||||
Investments
|
10,750,672 | (393,273) | 1,082,563 | |||
Foreign currency translation
|
— | — | — | |||
Net change in unrealized appreciation
(depreciation)
|
10,750,672 | (393,273) | 1,082,563 | |||
NET REALIZED AND UNREALIZED GAIN (LOSS)
|
8,407,614 | (445,966) | 5,475,071 | |||
NET INCREASE (DECREASE) IN NET ASSETS RESULTING
FROM OPERATIONS
|
$ 10,533,331 | $(395,321) | $ 6,112,257 |
(a) | Inception date is June 22, 2021, which is consistent with the commencement of investment operations and is the date the initial creation units were established. |
First
Trust Nasdaq Pharmaceuticals ETF (FTXH) |
First
Trust Nasdaq Retail ETF (FTXD) |
First
Trust Nasdaq Semiconductor ETF (FTXL) |
First
Trust Nasdaq Transportation ETF (FTXR) |
First
Trust Indxx Medical Devices ETF (MDEV) (a) | |||||
$153,209 | $124,301 | $358,859 | $4,481,405 | $27,005 | |||||
1 | — | 1 | 158 | — | |||||
— | — | — | 4,562,353 | — | |||||
— | — | (1,656) | — | (594) | |||||
24 | 38 | — | — | — | |||||
153,234 | 124,339 | 357,204 | 9,043,916 | 26,411 | |||||
64,518 | 40,796 | 235,311 | 3,419,885 | 51,358 | |||||
64,518 | 40,796 | 235,311 | 3,419,885 | 51,358 | |||||
88,716 | 83,543 | 121,893 | 5,624,031 | (24,947) | |||||
(223,766) | (58,432) | (1,057,292) | (26,820,656) | (1,587) | |||||
741,920 | 1,392,184 | 11,986,749 | 32,396,468 | — | |||||
— | — | — | — | (42) | |||||
518,154 | 1,333,752 | 10,929,457 | 5,575,812 | (1,629) | |||||
(452,347) | (919,587) | (8,926,609) | (81,898,218) | 543,059 | |||||
— | — | — | — | 27 | |||||
(452,347) | (919,587) | (8,926,609) | (81,898,218) | 543,086 | |||||
65,807 | 414,165 | 2,002,848 | (76,322,406) | 541,457 | |||||
$154,523 | $497,708 | $2,124,741 | $(70,698,375) | $516,510 |
First Trust Nasdaq Bank ETF (FTXO) |
First Trust Nasdaq Food & Beverage ETF (FTXG) | ||||||
Six
Months Ended 9/30/2021 (Unaudited) |
Year Ended 3/31/2021 |
Six
Months Ended 9/30/2021 (Unaudited) |
Year Ended 3/31/2021 | ||||
OPERATIONS: | |||||||
Net investment income (loss)
|
$ 2,125,717 | $ 2,496,898 | $ 50,645 | $ 37,996 | |||
Net realized gain (loss)
|
(2,343,058) | 18,011,029 | (52,693) | 219,178 | |||
Net change in unrealized appreciation
(depreciation)
|
10,750,672 | 49,898,872 | (393,273) | 819,716 | |||
Net increase (decrease) in net assets resulting
from operations
|
10,533,331 | 70,406,799 | (395,321) | 1,076,890 | |||
DISTRIBUTIONS TO SHAREHOLDERS FROM: | |||||||
Investment operations
|
(2,202,691) | (2,495,731) | (48,050) | (37,626) | |||
SHAREHOLDER TRANSACTIONS: | |||||||
Proceeds from shares sold
|
52,677,837 | 240,319,581 | 5,227,127 | 4,989,914 | |||
Cost of shares redeemed
|
(56,916,331) | (139,595,309) | (3,884,145) | (3,488,460) | |||
Net increase (decrease) in net assets resulting
from shareholder transactions
|
(4,238,494) | 100,724,272 | 1,342,982 | 1,501,454 | |||
Total increase (decrease) in net assets
|
4,092,146 | 168,635,340 | 899,611 | 2,540,718 | |||
NET ASSETS: | |||||||
Beginning of period
|
227,293,490 | 58,658,150 | 5,133,025 | 2,592,307 | |||
End of period
|
$231,385,636 | $227,293,490 | $6,032,636 | $5,133,025 | |||
CHANGES IN SHARES OUTSTANDING: | |||||||
Shares outstanding, beginning of period
|
7,300,002 | 3,750,002 | 200,002 | 150,002 | |||
Shares sold
|
1,650,000 | 8,200,000 | 200,000 | 200,000 | |||
Shares redeemed
|
(1,850,000) | (4,650,000) | (150,000) | (150,000) | |||
Shares outstanding, end of period
|
7,100,002 | 7,300,002 | 250,002 | 200,002 |
First Trust Nasdaq Oil & Gas ETF (FTXN) |
First Trust Nasdaq Pharmaceuticals ETF (FTXH) |
First Trust Nasdaq Retail ETF (FTXD) | ||||||||
Six
Months Ended 9/30/2021 (Unaudited) |
Year Ended 3/31/2021 |
Six
Months Ended 9/30/2021 (Unaudited) |
Year Ended 3/31/2021 |
Six
Months Ended 9/30/2021 (Unaudited) |
Year Ended 3/31/2021 | |||||
$ 637,186 | $ 385,232 | $ 88,716 | $ 172,248 | $ 83,543 | $ 40,918 | |||||
4,392,508 | 4,201,224 | 518,154 | 1,413,284 | 1,333,752 | 765,555 | |||||
1,082,563 | 5,482,034 | (452,347) | 2,106,357 | (919,587) | 1,880,553 | |||||
6,112,257 | 10,068,490 | 154,523 | 3,691,889 | 497,708 | 2,687,026 | |||||
(482,486) | (342,435) | (72,815) | (161,361) | (87,780) | (41,275) | |||||
48,291,433 | 37,358,049 | 2,582,284 | 20,157,542 | 23,644,511 | 8,716,861 | |||||
(41,034,062) | (17,521,673) | (3,953,355) | (10,364,671) | (11,363,446) | (5,537,780) | |||||
7,257,371 | 19,836,376 | (1,371,071) | 9,792,871 | 12,281,065 | 3,179,081 | |||||
12,887,142 | 29,562,431 | (1,289,363) | 13,323,399 | 12,690,993 | 5,824,832 | |||||
36,447,762 | 6,885,331 | 19,132,927 | 5,809,528 | 9,444,115 | 3,619,283 | |||||
$49,334,904 | $36,447,762 | $17,843,564 | $19,132,927 | $22,135,108 | $9,444,115 | |||||
2,350,002 | 850,002 | 750,002 | 300,002 | 300,002 | 200,002 | |||||
2,750,000 | 2,750,000 | 100,000 | 850,000 | 700,000 | 300,000 | |||||
(2,500,000) | (1,250,000) | (150,000) | (400,000) | (350,000) | (200,000) | |||||
2,600,002 | 2,350,002 | 700,002 | 750,002 | 650,002 | 300,002 |
First Trust Nasdaq Semiconductor ETF (FTXL) |
First Trust Nasdaq Transportation ETF (FTXR) | ||||||
Six
Months Ended 9/30/2021 (Unaudited) |
Year Ended 3/31/2021 |
Six
Months Ended 9/30/2021 (Unaudited) |
Year Ended 3/31/2021 | ||||
OPERATIONS: | |||||||
Net investment income (loss)
|
$ 121,893 | $ 248,285 | $ 5,624,031 | $ 451,189 | |||
Net realized gain (loss)
|
10,929,457 | 15,506,395 | 5,575,812 | 166,462,888 | |||
Net change in unrealized appreciation
(depreciation)
|
(8,926,609) | 17,121,367 | (81,898,218) | 97,342,785 | |||
Net increase (decrease) in net assets resulting
from operations
|
2,124,741 | 32,876,047 | (70,698,375) | 264,256,862 | |||
DISTRIBUTIONS TO SHAREHOLDERS FROM: | |||||||
Investment operations
|
(102,590) | (248,060) | (5,585,730) | (1,221,540) | |||
SHAREHOLDER TRANSACTIONS: | |||||||
Proceeds from shares sold
|
40,727,060 | 82,131,018 | 277,888,192 | 1,605,131,373 | |||
Cost of shares redeemed
|
(46,122,297) | (61,955,704) | (193,265,838) | (797,823,739) | |||
Net increase (decrease) in net assets resulting
from shareholder transactions
|
(5,395,237) | 20,175,314 | 84,622,354 | 807,307,634 | |||
Total increase (decrease) in net assets
|
(3,373,086) | 52,803,301 | 8,338,249 | 1,070,342,956 | |||
NET ASSETS: | |||||||
Beginning of period
|
84,156,152 | 31,352,851 | 1,071,854,314 | 1,511,358 | |||
End of period
|
$80,783,066 | $84,156,152 | $1,080,192,563 | $1,071,854,314 | |||
CHANGES IN SHARES OUTSTANDING: | |||||||
Shares outstanding, beginning of period
|
1,300,002 | 950,002 | 32,600,002 | 100,002 | |||
Shares sold
|
600,000 | 1,500,000 | 8,350,000 | 58,950,000 | |||
Shares redeemed
|
(700,000) | (1,150,000) | (5,900,000) | (26,450,000) | |||
Shares outstanding, end of period
|
1,200,002 | 1,300,002 | 35,050,002 | 32,600,002 |
(a) | Inception date is June 22, 2021, which is consistent with the commencement of investment operations and is the date the initial creation units were established. |
First
Trust Indxx Medical Devices ETF (MDEV) |
Period Ended 9/30/2021 (Unaudited) (a) |
$ (24,947) |
(1,629) |
543,086 |
516,510 |
— |
27,916,772 |
— |
27,916,772 |
28,433,282 |
— |
$28,433,282 |
— |
1,100,002 |
— |
1,100,002 |
Six Months Ended 9/30/2021 (Unaudited) |
Year Ended March 31, | Period Ended 3/31/2017 (a) | ||||||||||
2021 | 2020 | 2019 | 2018 | |||||||||
Net asset value, beginning of period
|
$ 31.14 | $ 15.64 | $ 24.41 | $ 29.50 | $ 25.94 | $ 20.01 | ||||||
Income from investment operations: | ||||||||||||
Net investment income (loss)
|
0.28 | 0.59 (b) | 0.73 | 0.84 | 0.40 | 0.07 | ||||||
Net realized and unrealized gain (loss)
|
1.46 | 15.50 | (8.77) | (5.14) | 3.56 | 5.91 | ||||||
Total from investment operations
|
1.74 | 16.09 | (8.04) | (4.30) | 3.96 | 5.98 | ||||||
Distributions paid to shareholders from: | ||||||||||||
Net investment income
|
(0.29) | (0.59) | (0.73) | (0.79) | (0.40) | (0.05) | ||||||
Net asset value, end of period
|
$32.59 | $31.14 | $15.64 | $24.41 | $29.50 | $25.94 | ||||||
Total return
(c)
|
5.63% | 105.13% | (33.93)% | (14.49)% | 15.35% | 29.89% | ||||||
Ratios to average net assets/supplemental data: | ||||||||||||
Net assets, end of period (in 000’s)
|
$ 231,386 | $ 227,293 | $ 58,658 | $ 168,447 | $ 1,314,444 | $ 1,027,400 | ||||||
Ratio of total expenses to average net
assets
|
0.60% (d) | 0.60% | 0.60% | 0.60% | 0.60% | 0.60% (d) | ||||||
Ratio of net investment income (loss) to average
net assets
|
1.80% (d) | 2.65% | 2.69% | 1.83% | 1.47% | 4.05% (d) | ||||||
Portfolio turnover rate (e)
|
29% | 176% | 59% | 87% | 39% | 7% |
(a) | Inception date is September 20, 2016, which is consistent with the commencement of investment operations and is the date the initial creation units were established. |
(b) | Based on average shares outstanding. |
(c) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all distributions at net asset value during the period, and redemption at net asset value on the last day of the period. The returns presented do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption or sale of Fund shares. Total return is calculated for the time period presented and is not annualized for periods of less than a year. |
(d) | Annualized. |
(e) | Portfolio turnover is calculated for the time period presented and is not annualized for periods of less than a year and does not include securities received or delivered from processing creations or redemptions and in-kind transactions. |
Six Months Ended 9/30/2021 (Unaudited) |
Year Ended March 31, | Period Ended 3/31/2017 (a) | ||||||||||
2021 | 2020 | 2019 | 2018 | |||||||||
Net asset value, beginning of period
|
$ 25.66 | $ 17.28 | $ 20.06 | $ 19.71 | $ 20.63 | $ 19.96 | ||||||
Income from investment operations: | ||||||||||||
Net investment income (loss)
|
0.20 | 0.32 | 0.27 | 0.27 | 0.35 | 0.14 | ||||||
Net realized and unrealized gain (loss)
|
(1.54) | 8.38 | (2.77) | 0.33 | (0.95) | 0.64 | ||||||
Total from investment operations
|
(1.34) | 8.70 | (2.50) | 0.60 | (0.60) | 0.78 | ||||||
Distributions paid to shareholders from: | ||||||||||||
Net investment income
|
(0.19) | (0.32) | (0.28) | (0.25) | (0.32) | (0.11) | ||||||
Net asset value, end of period
|
$24.13 | $25.66 | $17.28 | $20.06 | $19.71 | $20.63 | ||||||
Total return
(b)
|
(5.23)% | 50.65% | (12.69)% | 3.13% | (2.96)% | 3.91% | ||||||
Ratios to average net assets/supplemental data: | ||||||||||||
Net assets, end of period (in 000’s)
|
$ 6,033 | $ 5,133 | $ 2,592 | $ 2,006 | $ 985 | $ 5,158 | ||||||
Ratio of total expenses to average net
assets
|
0.60% (c) | 0.60% | 0.60% | 0.60% | 0.60% | 0.60% (c) | ||||||
Ratio of net investment income (loss) to average
net assets
|
1.60% (c) | 1.44% | 1.58% | 1.55% | 1.53% | 1.58% (c) | ||||||
Portfolio turnover rate (d)
|
40% | 131% | 59% | 108% | 76% | 54% |
(a) | Inception date is September 20, 2016, which is consistent with the commencement of investment operations and is the date the initial creation units were established. |
(b) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all distributions at net asset value during the period, and redemption at net asset value on the last day of the period. The returns presented do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption or sale of Fund shares. Total return is calculated for the time period presented and is not annualized for periods of less than a year. |
(c) | Annualized. |
(d) | Portfolio turnover is calculated for the time period presented and is not annualized for periods of less than a year and does not include securities received or delivered from processing creations or redemptions and in-kind transactions. |
Six Months Ended 9/30/2021 (Unaudited) |
Year Ended March 31, | Period Ended 3/31/2017 (a) | ||||||||||
2021 | 2020 | 2019 | 2018 | |||||||||
Net asset value, beginning of period
|
$ 15.51 | $ 8.10 | $ 18.91 | $ 19.95 | $ 20.63 | $ 19.84 | ||||||
Income from investment operations: | ||||||||||||
Net investment income (loss)
|
0.24 | 0.22 | 0.31 | 0.41 | 0.36 | 0.14 | ||||||
Net realized and unrealized gain (loss)
|
3.40 | 7.39 | (10.79) | (1.06) | (0.67) | 0.80 | ||||||
Total from investment operations
|
3.64 | 7.61 | (10.48) | (0.65) | (0.31) | 0.94 | ||||||
Distributions paid to shareholders from: | ||||||||||||
Net investment income
|
(0.18) | (0.20) | (0.32) | (0.39) | (0.33) | (0.15) | ||||||
Return of capital
|
— | — | (0.01) | — | (0.04) | — | ||||||
Total distributions
|
(0.18) | (0.20) | (0.33) | (0.39) | (0.37) | (0.15) | ||||||
Net asset value, end of period
|
$18.97 | $15.51 | $8.10 | $18.91 | $19.95 | $20.63 | ||||||
Total return
(b)
|
23.47% | 95.16% | (56.26)% | (3.27)% | (1.47)% | 4.75% | ||||||
Ratios to average net assets/supplemental data: | ||||||||||||
Net assets, end of period (in 000’s)
|
$ 49,335 | $ 36,448 | $ 6,885 | $ 12,294 | $ 3,991 | $ 2,063 | ||||||
Ratio of total expenses to average net
assets
|
0.60% (c) | 0.60% | 0.60% | 0.60% | 0.60% | 0.61% (c) (d) | ||||||
Ratio of net investment income (loss) to average
net assets
|
2.46% (c) | 2.01% | 2.14% | 1.69% | 1.96% | 1.30% (c) | ||||||
Portfolio turnover rate (e)
|
44% | 136% | 76% | 126% | 92% | 58% |
(a) | Inception date is September 20, 2016, which is consistent with the commencement of investment operations and is the date the initial creation units were established. |
(b) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all distributions at net asset value during the period, and redemption at net asset value on the last day of the period. The returns presented do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption or sale of Fund shares. Total return is calculated for the time period presented and is not annualized for periods of less than a year. |
(c) | Annualized. |
(d) | Includes excise tax. If this excise tax was not included, the expense ratio would have been 0.60%. |
(e) | Portfolio turnover is calculated for the time period presented and is not annualized for periods of less than a year and does not include securities received or delivered from processing creations or redemptions and in-kind transactions. |
Six Months Ended 9/30/2021 (Unaudited) |
Year Ended March 31, | Period Ended 3/31/2017 (a) | ||||||||||
2021 | 2020 | 2019 | 2018 | |||||||||
Net asset value, beginning of period
|
$ 25.51 | $ 19.36 | $ 21.50 | $ 21.14 | $ 19.83 | $ 20.12 | ||||||
Income from investment operations: | ||||||||||||
Net investment income (loss)
|
0.11 | 0.24 | 0.18 | 0.13 | 0.17 | 0.06 | ||||||
Net realized and unrealized gain (loss)
|
(0.04) (b) | 6.14 | (2.13) | 0.35 | 1.65 | (0.28) | ||||||
Total from investment operations
|
0.07 | 6.38 | (1.95) | 0.48 | 1.82 | (0.22) | ||||||
Distributions paid to shareholders from: | ||||||||||||
Net investment income
|
(0.09) | (0.23) | (0.19) | (0.12) | (0.17) | (0.06) | ||||||
Net realized gain
|
— | — | — | — | (0.34) | (0.01) | ||||||
Total distributions
|
(0.09) | (0.23) | (0.19) | (0.12) | (0.51) | (0.07) | ||||||
Net asset value, end of period
|
$25.49 | $25.51 | $19.36 | $21.50 | $21.14 | $19.83 | ||||||
Total return
(c)
|
0.28% | 33.00% | (9.13)% | 2.30% | 9.32% | (1.10)% | ||||||
Ratios to average net assets/supplemental data: | ||||||||||||
Net assets, end of period (in 000’s)
|
$ 17,844 | $ 19,133 | $ 5,810 | $ 5,376 | $ 2,114 | $ 1,983 | ||||||
Ratio of total expenses to average net
assets
|
0.60% (d) | 0.60% | 0.60% | 0.60% | 0.60% | 0.60% (d) | ||||||
Ratio of net investment income (loss) to average
net assets
|
0.83% (d) | 1.07% | 0.85% | 0.69% | 0.80% | 0.64% (d) | ||||||
Portfolio turnover rate (e)
|
34% | 83% | 42% | 107% | 70% | 48% |
(a) | Inception date is September 20, 2016, which is consistent with the commencement of investment operations and is the date the initial creation units were established. |
(b) | The per share amount does not correlate with the aggregate realized and unrealized gain (loss) due to the timing of the Fund share sales and repurchases in relation to market value fluctuation of the underlying investments. |
(c) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all distributions at net asset value during the period, and redemption at net asset value on the last day of the period. The returns presented do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption or sale of Fund shares. Total return is calculated for the time period presented and is not annualized for periods of less than a year. |
(d) | Annualized. |
(e) | Portfolio turnover is calculated for the time period presented and is not annualized for periods of less than a year and does not include securities received or delivered from processing creations or redemptions and in-kind transactions. |
Six Months Ended 9/30/2021 (Unaudited) |
Year Ended March 31, | Period Ended 3/31/2017 (a) | ||||||||||
2021 | 2020 | 2019 | 2018 | |||||||||
Net asset value, beginning of period
|
$ 31.48 | $ 18.10 | $ 22.34 | $ 20.86 | $ 19.68 | $ 19.90 | ||||||
Income from investment operations: | ||||||||||||
Net investment income (loss)
|
0.14 | 0.19 | 0.27 | 0.21 | 0.31 | 0.15 | ||||||
Net realized and unrealized gain (loss)
|
2.58 | 13.39 | (4.22) | 1.45 | 1.18 | (0.24) | ||||||
Total from investment operations
|
2.72 | 13.58 | (3.95) | 1.66 | 1.49 | (0.09) | ||||||
Distributions paid to shareholders from: | ||||||||||||
Net investment income
|
(0.15) | (0.20) | (0.29) | (0.18) | (0.31) | (0.13) | ||||||
Net asset value, end of period
|
$34.05 | $31.48 | $18.10 | $22.34 | $20.86 | $19.68 | ||||||
Total return
(b)
|
8.63% | 75.23% | (17.90)% | 7.98% | 7.63% | (0.45)% | ||||||
Ratios to average net assets/supplemental data: | ||||||||||||
Net assets, end of period (in 000’s)
|
$ 22,135 | $ 9,444 | $ 3,619 | $ 8,934 | $ 1,043 | $ 1,968 | ||||||
Ratio of total expenses to average net
assets
|
0.60% (c) | 0.60% | 0.60% | 0.60% | 0.60% | 0.61% (c) (d) | ||||||
Ratio of net investment income (loss) to average
net assets
|
1.23% (c) | 0.70% | 1.11% | 1.41% | 1.54% | 1.44% (c) | ||||||
Portfolio turnover rate (e)
|
52% | 114% | 65% | 127% | 126% | 65% |
(a) | Inception date is September 20, 2016, which is consistent with the commencement of investment operations and is the date the initial creation units were established. |
(b) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all distributions at net asset value during the period, and redemption at net asset value on the last day of the period. The returns presented do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption or sale of Fund shares. Total return is calculated for the time period presented and is not annualized for periods of less than a year. |
(c) | Annualized. |
(d) | Includes excise tax. If this excise tax was not included, the expense ratio would have been 0.60%. |
(e) | Portfolio turnover is calculated for the time period presented and is not annualized for periods of less than a year and does not include securities received or delivered from processing creations or redemptions and in-kind transactions. |
Six Months Ended 9/30/2021 (Unaudited) |
Year Ended March 31, | Period Ended 3/31/2017 (a) | ||||||||||
2021 | 2020 | 2019 | 2018 | |||||||||
Net asset value, beginning of period
|
$ 64.74 | $ 33.00 | $ 31.83 | $ 32.58 | $ 25.04 | $ 19.93 | ||||||
Income from investment operations: | ||||||||||||
Net investment income (loss)
|
0.11 | 0.23 | 0.38 | 0.25 | 0.14 | 0.05 | ||||||
Net realized and unrealized gain (loss)
|
2.56 | 31.75 | 1.18 | (0.79) | 7.54 | 5.11 | ||||||
Total from investment operations
|
2.67 | 31.98 | 1.56 | (0.54) | 7.68 | 5.16 | ||||||
Distributions paid to shareholders from: | ||||||||||||
Net investment income
|
(0.09) | (0.24) | (0.39) | (0.21) | (0.14) | (0.05) | ||||||
Net realized gain
|
— | — | — | — | — | (0.00) (b) | ||||||
Total distributions
|
(0.09) | (0.24) | (0.39) | (0.21) | (0.14) | (0.05) | ||||||
Net asset value, end of period
|
$67.32 | $64.74 | $33.00 | $31.83 | $32.58 | $25.04 | ||||||
Total return
(c)
|
4.12% | 97.11% | 4.82% | (1.62)% | 30.77% | 25.92% | ||||||
Ratios to average net assets/supplemental data: | ||||||||||||
Net assets, end of period (in 000’s)
|
$ 80,783 | $ 84,156 | $ 31,353 | $ 30,242 | $ 47,247 | $ 15,024 | ||||||
Ratio of total expenses to average net
assets
|
0.60% (d) | 0.60% | 0.60% | 0.60% | 0.60% | 0.60% (d) | ||||||
Ratio of net investment income (loss) to average
net assets
|
0.31% (d) | 0.45% | 1.00% | 0.78% | 0.55% | 0.66% (d) | ||||||
Portfolio turnover rate (e)
|
27% | 113% | 64% | 94% | 59% | 58% |
(a) | Inception date is September 20, 2016, which is consistent with the commencement of investment operations and is the date the initial creation units were established. |
(b) | Amount is less than $0.01. |
(c) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all distributions at net asset value during the period, and redemption at net asset value on the last day of the period. The returns presented do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption or sale of Fund shares. Total return is calculated for the time period presented and is not annualized for periods of less than a year. |
(d) | Annualized. |
(e) | Portfolio turnover is calculated for the time period presented and is not annualized for periods of less than a year and does not include securities received or delivered from processing creations or redemptions and in-kind transactions. |
Six Months Ended 9/30/2021 (Unaudited) |
Year Ended March 31, | Period Ended 3/31/2017 (a) | ||||||||||
2021 | 2020 | 2019 | 2018 | |||||||||
Net asset value, beginning of period
|
$ 32.88 | $ 15.11 | $ 23.33 | $ 24.93 | $ 22.78 | $ 19.94 | ||||||
Income from investment operations: | ||||||||||||
Net investment income (loss)
|
0.16 | 0.04 | 0.30 | 0.35 | 0.32 | 0.14 | ||||||
Net realized and unrealized gain (loss)
|
(2.06) | 17.79 | (8.22) | (1.62) | 2.16 | 2.84 | ||||||
Total from investment operations
|
(1.90) | 17.83 | (7.92) | (1.27) | 2.48 | 2.98 | ||||||
Distributions paid to shareholders from: | ||||||||||||
Net investment income
|
(0.16) | (0.06) | (0.30) | (0.33) | (0.33) | (0.14) | ||||||
Net realized gain
|
— | — | — | — | — | (0.00) (b) | ||||||
Total distributions
|
(0.16) | (0.06) | (0.30) | (0.33) | (0.33) | (0.14) | ||||||
Net asset value, end of period
|
$30.82 | $32.88 | $15.11 | $23.33 | $24.93 | $22.78 | ||||||
Total return
(c)
|
(5.80)% | 118.10% | (34.35)% | (5.11)% | 10.89% | 14.97% | ||||||
Ratios to average net assets/supplemental data: | ||||||||||||
Net assets, end of period (in 000’s)
|
$ 1,080,193 | $ 1,071,854 | $ 1,511 | $ 2,333 | $ 3,740 | $ 2,278 | ||||||
Ratio of total expenses to average net
assets
|
0.60% (d) | 0.60% | 0.60% | 0.60% | 0.60% | 0.61% (d) (e) | ||||||
Ratio of net investment income (loss) to average
net assets
|
0.99% (d) | 0.10% | 1.04% | 1.38% | 1.27% | 1.22% (d) | ||||||
Portfolio turnover rate (f)
|
26% | 129% | 89% | 108% | 78% | 28% |
(a) | Inception date is September 20, 2016, which is consistent with the commencement of investment operations and is the date the initial creation units were established. |
(b) | Amount is less than $0.01. |
(c) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all distributions at net asset value during the period, and redemption at net asset value on the last day of the period. The returns presented do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption or sale of Fund shares. Total return is calculated for the time period presented and is not annualized for periods of less than a year. |
(d) | Annualized. |
(e) | Includes excise tax. If this excise tax was not included, the expense ratio would have been 0.60%. |
(f) | Portfolio turnover is calculated for the time period presented and is not annualized for periods of less than a year and does not include securities received or delivered from processing creations or redemptions and in-kind transactions. |
Period Ended 9/30/2021 (a) (Unaudited) | |
Net asset value, beginning of period
|
$ 25.17 |
Income from investment operations: | |
Net investment income (loss)
|
(0.02) |
Net realized and unrealized gain (loss)
|
0.70 |
Total from investment operations
|
0.68 |
Net asset value, end of period
|
$25.85 |
Total return
(b)
|
2.70% |
Ratios to average net assets/supplemental data: | |
Net assets, end of period (in 000’s)
|
$ 28,433 |
Ratio of total expenses to average net
assets
|
0.70% (c) |
Ratio of net investment income (loss) to average
net assets
|
(0.34)% (c) |
Portfolio turnover rate (d)
|
1% |
(a) | Inception date is June 22, 2021, which is consistent with the commencement of investment operations and is the date the initial creation units were established. |
(b) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all distributions at net asset value during the period, and redemption at net asset value on the last day of the period. The return presented does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption or sale of Fund shares. Total return is calculated for the time period presented and is not annualized for periods of less than a year. |
(c) | Annualized. |
(d) | Portfolio turnover is calculated for the time period presented and is not annualized for periods of less than a year and does not include securities received or delivered from processing creations or redemptions and in-kind transactions. |
Fund | Index |
First Trust Nasdaq Bank ETF | Nasdaq US Smart Banks IndexTM |
First Trust Nasdaq Food & Beverage ETF | Nasdaq US Smart Food & Beverage IndexTM |
First Trust Nasdaq Oil & Gas ETF | Nasdaq US Smart Oil & Gas IndexTM |
First Trust Nasdaq Pharmaceuticals ETF | Nasdaq US Smart Pharmaceuticals IndexTM |
First Trust Nasdaq Retail ETF | Nasdaq US Smart Retail IndexTM |
First Trust Nasdaq Semiconductor ETF | Nasdaq US Smart Semiconductor IndexTM |
First Trust Nasdaq Transportation ETF | Nasdaq US Smart Transportation IndexTM |
First Trust Indxx Medical Devices ETF | Indxx Global Medical Equipment Index |
1) | the type of security; |
2) | the size of the holding; |
3) | the initial cost of the security; |
4) | transactions in comparable securities; |
5) | price quotes from dealers and/or third-party pricing services; |
6) | relationships among various securities; |
7) | information obtained by contacting the issuer, analysts, or the appropriate stock exchange; |
8) | an analysis of the issuer’s financial statements; and |
9) | the existence of merger proposals or tender offers that might affect the value of the security. |
1) | the value of similar foreign securities traded on other foreign markets; |
2) | ADR trading of similar securities; |
3) | closed-end fund or exchange-traded fund trading of similar securities; |
4) | foreign currency exchange activity; |
5) | the trading prices of financial products that are tied to baskets of foreign securities; |
6) | factors relating to the event that precipitated the pricing problem; |
7) | whether the event is likely to recur; and |
8) | whether the effects of the event are isolated or whether they affect entire markets, countries or regions. |
• | Level 1 – Level 1 inputs are quoted prices in active markets for identical investments. An active market is a market in which transactions for the investment occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
• | Level 2 – Level 2 inputs are observable inputs, either directly or indirectly, and include the following: |
o | Quoted prices for similar investments in active markets. |
o | Quoted prices for identical or similar investments in markets that are non-active. A non-active market is a market where there are few transactions for the investment, the prices are not current, or price quotations vary substantially either over time or among market makers, or in which little information is released publicly. |
o | Inputs other than quoted prices that are observable for the investment (for example, interest rates and yield curves observable at commonly quoted intervals, volatilities, prepayment speeds, loss severities, credit risks, and default rates). |
o | Inputs that are derived principally from or corroborated by observable market data by correlation or other means. |
• | Level 3 – Level 3 inputs are unobservable inputs. Unobservable inputs may reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the investment. |
Distributions paid from Ordinary Income |
Distributions paid from Capital Gains |
Distributions paid from Return of Capital | |||
First Trust Nasdaq Bank ETF
|
$ 2,495,731 | $ — | $ — | ||
First Trust Nasdaq Food & Beverage ETF
|
37,626 | — | — | ||
First Trust Nasdaq Oil & Gas ETF
|
342,435 | — | — | ||
First Trust Nasdaq Pharmaceuticals ETF
|
161,361 | — | — | ||
First Trust Nasdaq Retail ETF
|
41,275 | — | — | ||
First Trust Nasdaq Semiconductor ETF
|
248,060 | — | — | ||
First Trust Nasdaq Transportation ETF
|
1,221,540 | — | — |
Undistributed Ordinary Income |
Accumulated Capital and Other Gain (Loss) |
Net Unrealized Appreciation (Depreciation) | |||
First Trust Nasdaq Bank ETF
|
$ 222,145 | $ (70,379,091) | $ 5,102,524 | ||
First Trust Nasdaq Food & Beverage ETF
|
2,967 | (599,398) | 99,599 | ||
First Trust Nasdaq Oil & Gas ETF
|
42,797 | (6,238,725) | 2,789,833 | ||
First Trust Nasdaq Pharmaceuticals ETF
|
11,510 | (1,566,745) | 844,889 | ||
First Trust Nasdaq Retail ETF
|
4,375 | (1,559,624) | 673,462 | ||
First Trust Nasdaq Semiconductor ETF
|
22,586 | (4,005,170) | 12,290,664 | ||
First Trust Nasdaq Transportation ETF
|
— | (3,185,118) | 92,970,544 |
Non-Expiring Capital Loss Carryforward | |
First Trust Nasdaq Bank ETF
|
$ 70,379,091 |
First Trust Nasdaq Food & Beverage ETF
|
599,398 |
First Trust Nasdaq Oil & Gas ETF
|
6,238,725 |
First Trust Nasdaq Pharmaceuticals ETF
|
1,566,745 |
First Trust Nasdaq Retail ETF
|
1,559,624 |
First Trust Nasdaq Semiconductor ETF
|
4,005,170 |
First Trust Nasdaq Transportation ETF
|
3,185,118 |
Purchases | Sales | ||
First Trust Nasdaq Bank ETF | $ 67,954,508 | $ 67,515,947 | |
First Trust Nasdaq Food & Beverage ETF | 2,463,879 | 2,461,760 | |
First Trust Nasdaq Oil & Gas ETF | 22,273,479 | 22,029,214 | |
First Trust Nasdaq Pharmaceuticals ETF | 7,151,775 | 7,138,041 | |
First Trust Nasdaq Retail ETF | 7,148,548 | 6,972,908 | |
First Trust Nasdaq Semiconductor ETF | 21,073,820 | 21,050,745 | |
First Trust Nasdaq Transportation ETF | 291,142,577 | 290,392,691 | |
First Trust Indxx Medical Devices ETF | 755,697 | 161,063 | |
Purchases | Sales | ||
First Trust Nasdaq Bank ETF | $ 52,464,871 | $ 56,790,091 | |
First Trust Nasdaq Food & Beverage ETF | 5,212,517 | 3,873,418 | |
First Trust Nasdaq Oil & Gas ETF | 48,099,855 | 40,948,962 | |
First Trust Nasdaq Pharmaceuticals ETF | 2,578,347 | 3,947,418 | |
First Trust Nasdaq Retail ETF | 23,577,097 | 11,355,010 | |
First Trust Nasdaq Semiconductor ETF | 40,680,195 | 46,170,752 | |
First Trust Nasdaq Transportation ETF | 276,806,626 | 193,241,982 | |
First Trust Indxx Medical Devices ETF | 27,287,119 | — |
NOT FDIC INSURED | NOT BANK GUARANTEED | MAY LOSE VALUE |